# PEMETREXED DIPOTASSIUM

NDC: 83831-111
Generic name: pemetrexed dipotassium
Labeler / Manufacturer: Avyxa Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250101

FDA application: NDA210661

## Active ingredients

- PEMETREXED: 100 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83831-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83831-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=adc9ce4c-926a-4ee8-bd0d-d06fc89c17fc